NewsBenzingaBiomea Fusion Says Topline Data From Phase 1 Obesity Trial Of BMF-650 Now Expected In October, Pushed From Q3 Biomea Fusion Says Topline Data From Phase 1 Obesity Trial Of BMF-650 Now Expected In October, Pushed From Q3 Benzinga 2026.09.22 20:05 (GMT+0) Open on Benzinga Other news China's Central Bank: Do a Good Job in Financial Support for the Development of the AI Industry Peter Schiff Says AI Could Rewrite the Rules of Starting a Business: ‘Don’t Look for a Job’ Hunterbrook Report: Digital Realty’s $3 Billion Georgia Data Center Hits Toxic Roadblock After White Phosphorus Found At Former Army Dump Pre-market US stocks: Memory sector broadly higher, Micron Technology (MU.O) up 2.40% AbbVie’s Dual-Target Drug Shows Phase 2 Results for Hard-to-Treat Crohn’s Disease Musk announces he will gift one SpaceX share to every child in the U.S. next year
Hunterbrook Report: Digital Realty’s $3 Billion Georgia Data Center Hits Toxic Roadblock After White Phosphorus Found At Former Army Dump
